Inactive Instrument
Company Merchavia Holdings and Investments Ltd TEL AVIV STOCK EXCHANGE
Equities
MRHL
IL0002570146
Biotechnology & Medical Research
Business description: Merchavia Holdings and Investments Ltd
Geographical breakdown of sales: Merchavia Holdings and Investments Ltd
| Fiscal Period: December | 2021 (ILS) | 2022 (ILS) | 2023 (ILS) | 2024 (ILS) | 2025 (ILS) |
|---|---|---|---|---|---|
Israel | 10.61M | 4.16M | 1.85M | 119K | - |
Executive Committee: Merchavia Holdings and Investments Ltd
| Manager | Title | Age | Since |
|---|---|---|---|
Eli Arad
CEO | Chief Executive Officer | 53 | 2010-12-08 |
Ilan Goldstein
PSD | President | 65 | 2021-11-18 |
Eran Schenker
CTO | Chief Tech/Sci/R&D Officer | 63 | 2021-01-03 |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 71 | 2011-05-31 |
Composition of the Board of Directors: Merchavia Holdings and Investments Ltd
| Director | Title | Age | Since |
|---|---|---|---|
Rani Lifshitz
CHM | Chairman | 59 | 2014-05-26 |
Michal Aharon
BRD | Director/Board Member | 51 | 2014-05-10 |
Ophir Shahaf
BRD | Director/Board Member | 59 | 2019-03-13 |
Eyal Arieli
BRD | Director/Board Member | 64 | 2020-06-06 |
Sam Genzel
BRD | Director/Board Member | 61 | 2021-01-18 |
Company details: Merchavia Holdings and Investments Ltd
Other Biotechnology & Medical Research
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.39% | +0.94% | -1.26% | -11.08% | 45.62B | |
| -1.30% | +1.04% | +32.68% | +15.01% | 34.34B | |
| -2.25% | -0.31% | +26.01% | +18.55% | 29.46B | |
| +2.78% | +0.74% | +18.17% | -15.17% | 28.09B | |
| +41.35% | +42.93% | +281.58% | +514.79% | 19.11B | |
| +3.87% | +9.64% | +64.61% | +201.02% | 14.78B | |
| +11.87% | +4.57% | +3,276.98% | +4,354.88% | 14.25B | |
| +1.56% | +1.05% | +68.36% | +157.21% | 14.09B | |
| +1.15% | -2.99% | +36.63% | +3.91% | 13.25B | |
| Average | +6.60% | +6.02% | +422.64% | +582.13% | 23.67B | |
| Weighted average by Cap. | +4.88% | +4.65% | +266.79% | +362.77% |
